Infrastructure for a CMC Strategy
Wheeler Bio’s open-source platform is purpose-built for early development and clinical manufacturing but also forward-looking toward scalable commercial manufacturing. By embracing Pharma 4.0 principles, Wheeler is looking beyond clinical manufacturing to help customers build toward the future now. Through key collaborations with DataHow, Lucid Scientific, Emerson, Rockwell, and CRB, Wheeler has designed its development and manufacturing facilities to be a seamless integration of equipment, scalability, automation, data transparency, and process transferability. By offering open-source technology with easy data transfers and complete work packages, Wheeler bridges the gap between drug development to IND filing, and paves the way to faster commercial production.
Coupled with sound risk management and lean principles, Wheeler’s forward-looking facility designs are at the forefront of an evolving biomanufacturing industry.